Full-Time

Product Analyst

Inovalon

Inovalon

1,001-5,000 employees

Cloud-based healthcare data analytics and BI

Compensation Overview

$76.8k - $96k/yr

+ Performance-based incentives

No H1B Sponsorship

Canonsburg, PA, USA

Hybrid

Hybrid role; in-office Tue-Wed in Canonsburg, PA; travel <10% locally for training.

Category
Product (1)
Required Skills
Agile
Market Research
Usability Testing/Engineering
Forecasting
Visio
Word/Pages/Docs
JIRA
Confluence
Data Analysis
Excel/Numbers/Sheets
Requirements
  • 3+ years of experience in Product Analyst or similar role
  • Strong knowledge of Agile process and principles
  • Experience in the healthcare industry required
  • Strong interpersonal and collaboration skills
  • Must be able to interact with various cross-functional teams (Product, Development, Marketing, etc.) as well as clients and prospects
  • Knowledge of Microsoft Office (Word, Excel, Visio), Confluence, and JIRA
  • Experience in conducting market research
  • Ability to work both independently and as a team member in a fast paced, remote environment
  • Highly self-motivated / goal-oriented with strong analytical and problem-solving skills
  • Effectively leads projects and influences people to achieve department/company goals
  • Ability to organize material and complete writing assignment according to set standards regarding order, clarity, conciseness, style, and terminology
  • Strong knowledge of the documentation process from design to commercial release
  • Demonstrated ability to synthesize complex concepts and data into actionable goals and understandable documentation and presentations
  • Bachelor’s Degree in business administration, marketing, information technology, math, economics, or related field required
  • Travel for this position will include less than 10% locally usually for training purposes
Responsibilities
  • Analyze data and research the market and competition to identify market trends to identify product enhancements and new market opportunities
  • Forecast the costs of developing and marketing a product or feature, as well as potential revenue and profit
  • Create reports about the performance of a given product, and suggest possible improvements, which are done by reading reports and reviews
  • Conduct interviews or focus groups with existing customers and/or prospects to get feedback. May also include usability tests as well as anonymous surveys
  • Collaborate with cross-functional teams and other product lines
  • Partner with Marketing to explore entry / expansion into new markets, build and evaluate competitive pricing strategies
  • Evaluate the costs of development and launch and leverage market intelligence and product knowledge to suggest improvements to product and development teams
  • Monitor product performance and provide detailed insights and reports on product performance (sales / financials / transactions)
  • Maintain compliance with Inovalon’s policies, procedures and mission statement
  • Adhere to all confidentiality and HIPAA requirements as outlined within Inovalon’s Operating Policies and Procedures in all ways and at all times with respect to any aspect of the data handled or services rendered in the undertaking of the position; and
  • Fulfill those responsibilities and/or duties that may be reasonably provided by Inovalon for the purpose of achieving operational and financial success of the Employer
Desired Qualifications
  • Product management experience preferred

Inovalon provides a cloud-based platform that helps healthcare organizations turn data into actionable insights to improve patient care and operating performance. Its platform integrates real-time data from providers, payers, and life sciences, offering more than 100 analytics and BI tools for areas like revenue cycle management, care quality, and workforce management, accessed via subscriptions, with consulting services to maximize value. The company differentiates itself by offering a single, cloud-based platform with national-scale connectivity and real-time data access across multiple stakeholders, enabling end-to-end data-driven workflows. Its goal is to improve clinical outcomes, operational efficiency, and financial performance through data-driven decision support.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Bowie, Maryland

Founded

1997

Simplify Jobs

Simplify's Take

What believers are saying

  • Healthcare analytics market grows to $106.6B by 2032 at 12.4% CAGR.
  • Nordic Capital's $1.7B stake in February 2025 funds European AI expansion.
  • CMS April 2026 rules boost Inovalon's FHIR revenue cycle integrations.

What critics are saying

  • Google or AWS launches competing products, compressing Inovalon margins in 18-24 months.
  • Executive changes fail, eroding 5-10% market share yearly to Optum.
  • Payer consolidation cuts customer base as top 5 drive over 30% revenue.

What makes Inovalon unique

  • Inovalon's platform analyzes 95 billion medical events across 451 million lives.
  • Clinical Trial Eligibility Screener uses NLP for real-time patient matching.
  • AI-enabled prior authorization developed with Google Cloud partnership.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Inovalon who can refer or advise you

Benefits

Health Insurance

Life Insurance

401(k) Company Match

Paid Vacation

Hybrid Work Options

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

11%
Bio-IT World
Mar 11th, 2026
DoseMe Appoints Richard Malone, PharmD, MHA, as Vice President, Clinical & Science

DoseMe Appoints Richard Malone, PharmD, MHA, as Vice President, Clinical & Science. March 11, 2026 Seasoned pharmacy and healthcare technology leader to oversee clinical strategy, biostatistics and scientific innovation JUPITER, FL- March 12, 2026 - DoseMe, a global leader in model-informed precision dosing (MIPD) software, today announced the appointment of Richard Malone, PharmD, MHA, as Vice President, Clinical & Science. In this role, Malone will lead the company's clinical and scientific initiatives, including oversight of biostatistics, clinical content development, and alignment of scientific strategy with DoseMe's broader growth objectives, including integration of newly acquired capabilities from Firstline. The combined platform of DoseMe and Firstline unifies evidence-based antimicrobial selection with Bayesian model-informed precision dosing within a single, streamlined clinical workflow. Together, the integrated solution enables health systems to align stewardship strategy, prescribing guidance, and individualized dosing optimization to improve outcomes, reduce resistance risk, and enhance operational efficiency. "Richard's unique combination of frontline clinical expertise, operational leadership, and healthcare technology experience strengthens DoseMe's ability to deliver scientifically rigorous, clinically practical precision dosing solutions," said John Hardesky, CEO of DoseMe. "As we expand our platform with the integration of Firstline's clinical decision support capabilities, his leadership positions us to further advance Bayesian modeling and unified antimicrobial stewardship solutions for health systems worldwide." Malone brings more than 30 years of leadership experience spanning hospital pharmacy operations, investigational drug services, healthcare software, and executive sales leadership. Malone will manage the team of biostatisticians responsible for building and advancing clinical models within the DoseMe platform and serve as the company liaison to the DoseMe Clinical Advisory Board. He will also play a key role in ensuring alignment between scientific innovation and the company's strategic roadmap. "I'm excited to join DoseMe at a time when precision dosing and model-informed drug therapy are becoming central to modern antimicrobial stewardship and patient safety," said Malone. "I look forward to strengthening the company's scientific foundation while supporting scalable growth." Most recently, Malone served as Vice President, Sales at Inovalon, where he led the Care Management business unit's national sales operations. Under his leadership, the team accelerated growth to $3.6 million in new annual contract value in 2024 and achieved greater than 100% net revenue retention, followed by 140% year-over-year ARR growth in the first half of 2025. Prior to Inovalon, Malone was president of McCreadie Group LLC, a healthcare software company acquired by Cordance Operations. During his tenure, the organization achieved 24% year-over-year growth and 28% EBITDA, while expanding its SaaS solutions supporting pharmaceutical research sites and pharmacy residency programs. Malone also brings deep academic medical center experience. He served for nearly a decade as Program Director of the Investigational Drug Service at Vanderbilt University Medical Center, where he led consolidation and expansion of research pharmacy services across the enterprise, improved quality metrics to over 99%, and transitioned the department to a positive operating margin within 12 months. Earlier in his career, he held executive pharmacy leadership roles including Director of Pharmacy at Centennial Medical Center and Maury Regional Medical Center, as well as Corporate Director of Pharmacy Operations for Vanguard Health Systems, overseeing pharmacy strategy across a 25-hospital system. Malone earned his Doctor of Pharmacy with honors from the University of Tennessee College of Pharmacy and a Master of Science in Health Care Administration from the University of Maryland University College. He completed his Pharmacy Practice Residency at Saint Thomas Hospital in Nashville, Tennessee. About DoseMe DoseMe is the provider of Firstline and DoseMeRx clinical decision support technologies that enable proactive, personalized care. Firstline is a mobile-first platform making treatment guidance accessible to every clinician, anywhere. DoseMeRx delivers clinically validated PK/PD models to individualize precision dosing in seconds. DoseMe's evidence-based clinical intelligence helps reduce adverse drug events, antibiotic overuse, improved adherence to stewardship guidance, and provides clinicians a clear path to optimal care. For more information and real-world success stories, visit https://doseme-rx.com/success-stories * News briefs American Journal of Health-System Pharmacy, 2021 * ASHP Executive Forums on Cold Chain Management of Pharmaceuticals in Health Systems American Journal of Health-System Pharmacy * SITC Appoints James Gulley as Vice President ASH Clinical News, 2022 * ASHP Distinguished Leadership Award Kate Traynor, American Journal of Health-System Pharmacy, 2022 * Appointment American Journal of Health-System Pharmacy, 2021

Lite Rock V1047
Feb 5th, 2026
SSM Health Good Samaritan Hospital Named to Inaugural Forbes Top Hospitals 2026 Lists

SSM Health Good Samaritan Hospital named to inaugural Forbes Top Hospitals 2026 lists. * Posted By: Withers Syndication * February 5, 2026 @ 12:43 pm * Local News MT. VERNON - SSM Health Good Samaritan Hospital in Mt. Vernon has been recognized as one of the top-performing hospitals in the nation on the inaugural Forbes Top Hospitals 2026 list. This prestigious ranking evaluates hospitals based on excellence in patient care, clinical outcomes, value, and patient experience. SSM Health Good Samaritan Hospital is proud to be among the 10 SSM Health hospitals recognized this year for their outstanding quality and compassionate care. This first-of-its-kind list was created to help consumers navigate the increasingly complex healthcare landscape. Forbes partnered with Inovalon, a leading healthcare analytics company, and collaborated with experts in medicine, health policy, and patient advocacy to develop a rigorous, data-driven evaluation for the rankings. This recognition reflects the commitment of SSM Health physicians, nurses, caregivers, and support staff who prioritize patient care daily, delivering exceptional, patient-centered services to the communities they serve. "Being included on this list is an extraordinary honor and a true reflection of the commitment our team demonstrates every day," stated Damon Harbison, President of SSM Health Good Samaritan Hospital, SSM Health St. Mary's Hospital, and SSM Health Rural Health Network in Illinois. "We are extremely proud of what this achievement means for our patients and the communities of southern Illinois."

PR Newswire
Jan 20th, 2026
Inovalon launches Clinical Trial Eligibility Screener to speed up patient recruitment

Inovalon has launched Clinical Trial Eligibility Screener, a new API service designed to accelerate clinical trial recruitment by evaluating patient eligibility against study criteria in real time using longitudinal medical data. The service addresses persistent recruitment challenges in clinical research, where 86% of sites miss enrolment targets and up to half enrol one or no patients. Traditional pre-screening methods like telephone interviews often prove inefficient when patients are ultimately ineligible. The API uses natural language processing to interpret trial eligibility criteria and returns a pass, fail or inconclusive status for each requirement. This enables sponsors, clinical research organisations and recruitment vendors to quickly verify patient-reported medical histories and prioritise likely-eligible participants, reducing time and resources spent on ineligible candidates. Inovalon's platform draws on data from over 95 billion medical events across 451 million unique lives.

HIT Consultant
Aug 26th, 2025
Inovalon and Google Cloud Partner to Launch AI-Enabled Prior Authorization Solution

- Inovalon, a provider of solutions that empower data-driven healthcare, has announced a new collaboration with Google Cloud to develop an AI-enabled solution designed to address administrative burdens in the healthcare industry.

Stock Titan
Aug 19th, 2025
Inovalon Launches AI Solution in Partnership With AWS To Help Health Plans Meet New RADV Audit Requirements

Inovalon launches AI solution in partnership with AWS to help Health Plans meet new RADV Audit requirements.